Cardinal Health Boosts Fiscal 2026 Forecast and Strategic Initiatives
Cardinal Health has announced an increase in its financial projections for fiscal year 2026. The company is now predicting non-GAAP diluted earnings per share (EPS) to reach at least $10.00, up from the previous guidance of $9.65 to $9.85. This positive adjustment showcases the company's confidence in its performance and strategic direction.
Robust Specialty Growth Ahead
In a significant prediction, Cardinal Health anticipates its Specialty revenues will exceed $50 billion in fiscal 2026. This is expected to reflect a remarkable 16% compounded annual growth rate (CAGR) over the next three years. Such growth can be attributed to an increasing demand for specialty distribution, the expansion of its Managed Services Organization (MSO) platforms, and project robust growth within its BioPharma Solutions sector.
BioPharma Solutions Initiatives
Highlighting success within its BioPharma Solutions division, Cardinal Health points to the achievements of its Sonexus™ Access and Patient Support business. Recently, several leading manufacturers have chosen Sonexus™ for their patient support programs, collectively helping over 1 million patients manage their health more effectively. Notably, this includes a transition of the Dupixent My Way patient support program for Sanofi and Regeneron.
The advancements stem from Cardinal Health's strategic investments in innovation and technology aimed at enhancing the patient support experience through digital solutions.
Adapting to Regulatory Changes
Cardinal Health successfully adjusted its manufacturer distribution service agreements in light of the changes brought about by the 2026 Medicare Drug Price Negotiation Program. This timely transition ensures that the company can continue to fulfill its crucial roles in the healthcare supply chain while navigating new regulatory landscapes.
The company has expressed confidence that it will be compensated fairly for its essential services, which ensure the secure and efficient delivery of pharmaceuticals to customers.
Launch of ContinuCare™ Pathway
Taking steps to enhance patient care, Cardinal Health's at-Home Solutions division has rolled out the ContinuCare™ Pathway program. This innovative initiative aims to simplify the management of diabetes supplies while further integrating resources from its Advanced Diabetes Supply acquisition.
Partnership with Publix Super Markets
The ContinuCare™ Pathway is designed to assist pharmacies and patients in navigating complex insurance processes, particularly for direct home delivery of diabetes supplies covered under medical benefits. Publix Super Markets Inc. has enrolled its entire pharmacy network in this program, significantly expanding its reach to over 11,000 retail pharmacies.
This partnership illustrates Cardinal Health's commitment to enhancing patient outcomes through accessible and efficient healthcare solutions.
Upcoming Investor Events
Cardinal Health plans to share more insightful details during the ongoing J.P. Morgan Healthcare Conference, with presentations scheduled to begin shortly. Investors and market watchers are encouraged to tune in for updates on the company's strategic progress.
About Cardinal Health
Cardinal Health is a leading distributor of pharmaceuticals and specialty products, a global manufacturer, and distributor of medical and laboratory products. The company also manages home-health products and services while providing comprehensive performance solutions driven by a customer-centric focus.
Frequently Asked Questions
What is the new EPS forecast for Cardinal Health in fiscal 2026?
The company has raised its EPS forecast to at least $10.00 for fiscal 2026.
What revenue growth is expected in Cardinal Health's Specialty sector?
The company anticipates Specialty revenues will exceed $50 billion, reflecting a 16% CAGR over three years.
How is Cardinal Health adapting to regulatory changes?
Cardinal Health has successfully transitioned its distribution service agreements in response to the 2026 Medicare Drug Price Negotiation Program.
What is the ContinuCare™ Pathway program offered by Cardinal Health?
This is an innovative program launched to simplify diabetes supply management for pharmacies and patients, providing efficient home delivery options.
How is Cardinal Health supporting its BioPharma Solutions division?
The company has made strategic investments in product innovation and technology to enhance patient support through its Sonexus™ business.
